Mr Hall joined Micro-X in February 2020 as Chief Financial Offer and Company Secretary with overall responsibility for the Company’s finances and to strengthen Micro X’s commercial leadership. Mr Hall has been a key member of the leadership team driving financial strategy and capital markets activities as well as playing an integral role in the $15m strategic partnership and funding agreement with Varex Imaging in late 2022.
Mr Hall’s appointment as Chief Executive Officer comes at a time when the Company has identified the need for a shift of emphasis from technical to commercial leadership. Kingsley will work closely with two talented technical leaders, Anthony Skeats as Chief Operating Officer and Dr Brian Gonzales as CEO – Americas and Chief Scientific Officer. This leadership change comes at a critical time for Micro-X as it prepares for the final steps to commercially launch its first security product, the Argus X-ray Camera.
“Kingsley comes into the role of Micro-X CEO with deep knowledge of our culture, our commercial strategies, as well as our partners and shareholders. Kingsley is a leader with a strong commercial and financial background making him an ideal candidate to take on the CEO role. Micro-X is focussed on providing career development opportunities right across the business and it is therefore pleasing to have appointed an internal successor.” – Micro-X Chair David Knox
Mr Hall said he was both proud and excited to have the opportunity to lead an Australian company with world-leading talent and technology.
“I believe there are exceptional commercial opportunities available to us in our target markets of healthcare, security and defence,” Mr Hall said.
“Micro-X is an outstanding technology company with a team of deeply dedicated and exceptional people who are passionate about what we do.”
“I am also indebted to Peter Rowland for his support and mentorship. While our team has much to do, he is leaving Micro-X with multiple products capable of securing leading positions in multi-billion-dollar markets.”
“The strength of our Engineering, Development and Manufacturing teams allows my immediate focus to be on driving further commercial returns from our technology, including a successful commercial launch of the Argus by mid 2023 and addressing sales and profitability in our Mobile DR Division. We will also advance our airport checkpoint products to more commercial readiness once we deliver working prototypes to the TSA this year.”
Peter Rowland registered Micro-X as a company in Melbourne in September 2011 and has led its evolution since then to become a global leader in revolutionary x-ray imaging technology. The transition to new leadership for the next phase of commercial growth comes ahead of the launch of the Argus X-ray Camera, Micro-X’s second disruptive x-ray product and as its pathway to market firms for the Airport Checkpoints and Stroke CT Imager businesses.
Following his retirement as Managing Director and CEO, Mr Rowland will be available for the next six months to assist in a transition as a Non-Executive Director on the Board. He will retire at the November 2023 AGM.
Mr Knox thanked Mr Rowland for his significant contribution as founder and CEO.
“On behalf of the whole Board of Directors and staff at Micro-X, I cannot thank Peter enough for bringing the Company this far,” Mr Knox said.
“His vision, energy and leadership has turned an idea into a company that is emerging as a force in global radiology and security markets. The culture of the organisation, the creativity and commitment of everyone involved at Micro-X are of his creation and position the Company well for the exciting expansion in our next phase.”
“Under Peter’s leadership, Micro-X has transformed from a novel idea developed around carbon nanotube technology through to an ASX listed company with a world class engineering and manufacturing operation in Tonsley and a global footprint across the United States and Europe.”
“By securing global partners such as Varex Imaging and collaborators including the TSA and ASA, he has greatly strengthened the business we are today. Above all else, Peter’s legacy will be our culture of innovation, collaboration and dedication. I thank him for his insights, tenacity and leadership throughout his tenure as CEO of Micro-X.”
More information can be found here:
$15m strategic partnership and funding agreement with Varex Imaging
Mr Hall joined Micro-X in February 2020 as Chief Financial Offer and Company Secretary with overall responsibility for the Company’s finances and to strengthen Micro X’s commercial leadership. Mr Hall has been a key member of the leadership team driving financial strategy and capital markets activities as well as playing an integral role in the $15m strategic partnership and funding agreement with Varex Imaging in late 2022.
Mr Hall’s appointment as Chief Executive Officer comes at a time when the Company has identified the need for a shift of emphasis from technical to commercial leadership. Kingsley will work closely with two talented technical leaders, Anthony Skeats as Chief Operating Officer and Dr Brian Gonzales as CEO – Americas and Chief Scientific Officer. This leadership change comes at a critical time for Micro-X as it prepares for the final steps to commercially launch its first security product, the Argus X-ray Camera.
“Kingsley comes into the role of Micro-X CEO with deep knowledge of our culture, our commercial strategies, as well as our partners and shareholders. Kingsley is a leader with a strong commercial and financial background making him an ideal candidate to take on the CEO role. Micro-X is focussed on providing career development opportunities right across the business and it is therefore pleasing to have appointed an internal successor.” – Micro-X Chair David Knox
Mr Hall said he was both proud and excited to have the opportunity to lead an Australian company with world-leading talent and technology.
“I believe there are exceptional commercial opportunities available to us in our target markets of healthcare, security and defence,” Mr Hall said.
“Micro-X is an outstanding technology company with a team of deeply dedicated and exceptional people who are passionate about what we do.”
“I am also indebted to Peter Rowland for his support and mentorship. While our team has much to do, he is leaving Micro-X with multiple products capable of securing leading positions in multi-billion-dollar markets.”
“The strength of our Engineering, Development and Manufacturing teams allows my immediate focus to be on driving further commercial returns from our technology, including a successful commercial launch of the Argus by mid 2023 and addressing sales and profitability in our Mobile DR Division. We will also advance our airport checkpoint products to more commercial readiness once we deliver working prototypes to the TSA this year.”
Peter Rowland registered Micro-X as a company in Melbourne in September 2011 and has led its evolution since then to become a global leader in revolutionary x-ray imaging technology. The transition to new leadership for the next phase of commercial growth comes ahead of the launch of the Argus X-ray Camera, Micro-X’s second disruptive x-ray product and as its pathway to market firms for the Airport Checkpoints and Stroke CT Imager businesses.
Following his retirement as Managing Director and CEO, Mr Rowland will be available for the next six months to assist in a transition as a Non-Executive Director on the Board. He will retire at the November 2023 AGM.
Mr Knox thanked Mr Rowland for his significant contribution as founder and CEO.
“On behalf of the whole Board of Directors and staff at Micro-X, I cannot thank Peter enough for bringing the Company this far,” Mr Knox said.
“His vision, energy and leadership has turned an idea into a company that is emerging as a force in global radiology and security markets. The culture of the organisation, the creativity and commitment of everyone involved at Micro-X are of his creation and position the Company well for the exciting expansion in our next phase.”
“Under Peter’s leadership, Micro-X has transformed from a novel idea developed around carbon nanotube technology through to an ASX listed company with a world class engineering and manufacturing operation in Tonsley and a global footprint across the United States and Europe.”
“By securing global partners such as Varex Imaging and collaborators including the TSA and ASA, he has greatly strengthened the business we are today. Above all else, Peter’s legacy will be our culture of innovation, collaboration and dedication. I thank him for his insights, tenacity and leadership throughout his tenure as CEO of Micro-X.”
More information can be found here:
$15m strategic partnership and funding agreement with Varex Imaging
$1.5M Varex milestone achieved. Australian hi-tech company Micro-X Ltd (ASX:MX1) (Micro-X or the Company), a leader in cold cathode X-ray technology for health and security markets globally, is pleased to announce the achievement of the fifth and final milestone under the Varex licence agreement.
It’s a pleasure to deliver to you our second newsletter with updates and insights into our achievements across the business.
Read about the design of Micro-X's Head CT from Dr Nyein Chan Aung, Monash University Design Health Collab.
Micro-X creates revolutionary X-ray technology to better lives.
Our PurposeFind out how Micro-X is creating new opportunities for industries across the world.
Find out moreThey’re the visionaries and innovators behind our X-ray technology, products, culture and ethos.
Meet the team